The interaction of DNA-targeted platinum phenanthridinium complexes with DNA

被引:61
作者
Whittaker, J
McFadyen, WD
Wickham, G
Wakelin, LPG
Murray, V [1 ]
机构
[1] Univ New S Wales, Sch Biochem & Mol Genet, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia
[3] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia
[4] Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
D O I
10.1093/nar/26.17.3933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cisplatin analogues were synthesised that consisted of platinum(ll) diamine complexes tethered via a polymethylene chain (n = 3, 5, 8 and 10) to a phenanthridinium cation, Both chloro and iodo leaving groups were examined. DNA adduct formation was quantitatively analysed using a linear amplification system with the plasmid pGEM-3Zf(+). This system utilised Tag DNA polymerase to extend from an oligonucleotide primer to the damage site. This damage site inhibited the extension of the DNA polymerase. The products were electrophoresed on a DNA sequencing gel enabling adduct formation to be determined at base pair resolution. The damage intensity at each site was determined by densitometry. The platinum phenanthridinium complexes were shown to damage DNA at shorter incubation times than cisplatin. To produce similar levels of damage, an 18 h incubation was required for cisplatin compared to 30 min for the n = 3 platinum phenanthridinium complexes; this indicates that the intercalating chromophore causes a large increase in the rate of platination, A reaction mechanism involving direct displacement of the chloride by the N-7 of guanine may account for the rate increase. These results indicate that further development of these compounds could lead to more effective cancer chemotherapeutic agents.
引用
收藏
页码:3933 / 3939
页数:7
相关论文
共 38 条
[1]  
ANDREWS PA, 1985, CANCER RES, V45, P6250
[2]   PT-195 NMR KINETIC AND MECHANISTIC STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM AND TRANS-DIAMMINEDICHLOROPLATINUM(II) BINDING TO DNA [J].
BANCROFT, DP ;
LEPRE, CA ;
LIPPARD, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (19) :6860-6871
[3]  
Bruhn S.L., 1991, PROG INORG CHEM BIOI, V38, P478
[4]  
CHRISTIAN MC, 1992, SEMIN ONCOL, V19, P720
[5]  
Coley RF, 1973, INORG CHIM ACTA, V7, P573
[6]   REPLICATION INHIBITION AND TRANSLESION SYNTHESIS ON TEMPLATES CONTAINING SITE-SPECIFICALLY PLACED CIS-DIAMMINEDICHLOROPLATINUM(II) DNA ADDUCTS [J].
COMESS, KM ;
BURSTYN, JN ;
ESSIGMANN, JM ;
LIPPARD, SJ .
BIOCHEMISTRY, 1992, 31 (16) :3975-3990
[7]  
Dabrowiak J C, 1987, Prog Med Chem, V24, P129, DOI 10.1016/S0079-6468(08)70421-1
[8]  
DENNY WA, 1989, ANTI-CANCER DRUG DES, V4, P241
[9]   SURFACE AND ELECTROSTATIC CONTRIBUTIONS TO DNA-PROMOTED REACTIONS OF PLATINUM(II) COMPLEXES WITH SHORT OLIGONUCLEOTIDES - A KINETIC-STUDY [J].
ELMROTH, SKC ;
LIPPARD, SJ .
INORGANIC CHEMISTRY, 1995, 34 (21) :5234-5243
[10]  
Fan JY, 1997, ANTI-CANCER DRUG DES, V12, P181